title: Zirconium Phosphate Nanoplatelet Potential for Anticancer Drug Delivery Applications.
abstract: Zirconium phosphate (ZrP) nanoplatelets can intercalate anticancer agents via an ion exchange reaction creating an inorganic delivery system with potential for cancer treatment. ZrP delivery of anticancer agents inside tumor cells was explored in vitro. Internalization and cytotoxicity of ZrP nanoplatelets were studied in MCF-7 and MCF-10A cells. DOX-loaded ZrP nanoplatelets (DOX@ZrP) uptake was assessed by confocal (CLSM) and transmission electron microscopy (TEM). Cytotoxicity to MCF-7 and MCF-10A cells was determined by the MTT assay. Reactive Oxy- gen Species (ROS) production was analyzed by fluorometric assay, and cell cycle alterations and induction of apoptosis were analyzed by flow cytometry. ZrP nanoplatelets were localized in the endosomes of MCF-7 cells. DOX and ZrP nanoplatelets were co-internalized into MCF-7 cells as detected by CLSM. While ZrP showed limited toxicity to MCF-7 cells, DOX@ZrP was cytotoxic at an IC₅₀ similar to that of free DOX. Meanwhile, DOX lC₅₀ was significantly lower than the equivalent concentration of DOX@ZrP in MCF-10A cells. ZrP did not induce apoptosis in both cell lines. DOX and DOX@ZrP induced significant oxidative stress in both cell models. Results suggest that ZrP nanoplatelets are promising as carriers of anticancer agents into cancer cells.
authors.forename: Millie L
authors.initials: ML
authors.lastname: González
authors.forename: Mayra
authors.initials: M
authors.lastname: Ortiz
authors.forename: Carmen
authors.initials: C
authors.lastname: Hernández
authors.forename: Jennifer
authors.initials: J
authors.lastname: Cabán
authors.forename: Axel
authors.initials: A
authors.lastname: Rodríguez
authors.forename: Jorge L
authors.initials: JL
authors.lastname: Colón
authors.forename: Adriana
authors.initials: A
authors.lastname: Báez
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D004317:Doxorubicin / Q000737:chemistry / Q000494:pharmacology; D004337:Drug Carriers / Q000737:chemistry / Q000494:pharmacology; D005260:Female; D006801:Humans; D061986:MCF-7 Cells; D053758:Nanoparticles / Q000737:chemistry*; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D015040:Zirconium / Q000737:chemistry / Q000494:pharmacology
chemical_list: D004337:Drug Carriers; C027006:zirconium phosphate; D004317:Doxorubicin; D015040:Zirconium